XENE – xenon pharmaceuticals inc. - common shares (US:NASDAQ)
Stock Stats
News
Xenon Pharmaceuticals (XENE) Up 2.4% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]
Xenon Pharmaceuticals Inc. (NASDAQ: XENE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $53.00 price target on the stock.
Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study in FOS at AES 2024 [Canadian Business Journal (Canada)]
Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study in FOS at AES 2024 [Yahoo! Finance]
Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study in FOS at AES 2024
Form 4 Xenon Pharmaceuticals For: Dec 18 Filed by: AULIN SHERRY
Form 144 Xenon Pharmaceuticals Filed by: AULIN SHERRY
Form 4 Xenon Pharmaceuticals For: Nov 22 Filed by: PATOU GARY
Form 144 Xenon Pharmaceuticals Filed by: PATOU GARY
Form 10-Q Xenon Pharmaceuticals For: Sep 30
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.